SCHEMBL2858904

SCHEMBL2858904

NC1CCC[C@@H](C(=O)O)NC(=O)c2ccccc2C1=O

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 9/20 0.38
▸ ACE P12821 5/20 0.37
▸ PARP1 P09874 1/20 0.35
▸ MAPT P10636 3/20 0.35
▸ GAA P10253 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ LMNA P02545 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ HTR2B P41595 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ HBB P68871 1/20 0.34
▸ ITGB1 P05556 3/20 0.34
▸ ITGA2 P17301 3/20 0.34
▸ ANPEP P15144 1/20 0.34
▸ LNPEP Q9UIQ6 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8801345 0.75 POLB (0.35) MAPTGAAHSD17B10TP53CYP1A2
SCHEMBL17675155 0.72 MAPT (0.46) MMEACEPARP1MAPTGAA
SCHEMBL8585951 0.69 MAPT (0.44) MAPTHSD17B10LMNATP53CYP1A2
SCHEMBL27423471 0.69 MME (0.43) MMEACEANPEPLNPEP
SCHEMBL125094 0.69 MAPT (0.44) MAPTHSD17B10LMNATP53CYP1A2
SCHEMBL1252255 0.68 GAA (0.62) MMEACEPARP1MAPTGAA
SCHEMBL1252254 0.68 GAA (0.62) MMEACEPARP1MAPTGAA
SCHEMBL2080900 0.68 GAA (0.62) MMEACEPARP1MAPTGAA
SCHEMBL27423478 0.68 MME (0.43) MMEACEMAPTTP53
Phthalimide SCHEMBL28667674 0.66 GSK3B (0.54) MAPTHSD17B10LMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2143728-A1 Improved process for the preparation of copolymer-1 Momenta Pharmaceuticals, Inc. (US) 2010-01-13 — — EP disclosed
EP-2046817-B1 IMPROVED PROCESS FOR THE PREPARATION OF COPOLYMER-1 MOMENTA PHARMACEUTICALS INC (US) 2009-12-16 — — EP disclosed
EP-2046817-A1 IMPROVED PROCESS FOR THE PREPARATION OF COPOLYMER-1 Momenta Pharmaceuticals, Inc. (US) 2009-04-15 — — EP disclosed
US-20080021192-A1 PROCESS FOR THE PREPARATION OF COPOLYMER-1 MOMENTA PHARMACEUTICALS, INC. (US) 2008-01-24 — — US disclosed
WO-2008006026-A1 IMPROVED PROCESS FOR THE PREPARATION OF COPOLYMER-1 MOMENTA PHARMACEUTICALS, INC. (US) 2008-01-10 — — WO disclosed
Send feedback